GPT-Rosalind
GPT-Rosalind is a released agents and json / tool use model; evaluate it while provider pricing coverage matures.
- Family
- GPT-Rosalind
- Released
- 2026-04-16
- Architecture
- Decoder Only
- Specialization
- medical
- Openness
- Proprietary
- License
- ProprietaryRestricted
- Weights
- Not released
- Code
- Unknown
No tracked provider pricing is available yet.
About
GPT-Rosalind is OpenAI's frontier reasoning model purpose-built for life sciences research, including biology, drug discovery, translational medicine, genomics analysis, and biodefense. OpenAI's June 3, 2026 capabilities update merged GPT-5.5-style agentic coding and tool-use strengths into Rosalind while improving life-sciences performance; OpenAI reported it outperformed GPT-5.5 across tested life-sciences domains and used 31% fewer tokens for genomics analyses. Access remains restricted to qualified researchers and public-health partners through trusted access programs, including the Rosalind Biodefense program for US government and allied organizations. Parameters, context window, and pricing are not publicly disclosed.
Providers
No active provider routes are tracked for this model yet.
Capabilities
Benchmark peer barsfor Agents
No task-mapped benchmark peers are available for this model yet.
Migration checks
No linked migration route is available for this model yet.